Identification and multi-layered validation of seven diagnostic biomarkers for dilated cardiomyopathy via integrative machine learning, single-cell transcriptomics, and Mendelian randomization
Frontiers in Cell and Developmental Biology · 09.06.2026 · 14
DOI: 10.3389/fcell.2026.1851275 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Cell and Developmental Biology, online erschienen am 09.06.2026. Verfasst von Jingwei Li und 5 weiteren Autor:innen. Beteiligte Einrichtung: College of Clinical Traditional Chinese Medicine, Gansu University of Chinese Medicine, Lanzhou, China. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Science and Technology Program of Gansu Province.
Abstract (Originalsprache)
Background
Dilated cardiomyopathy (DCM) is the most common non-ischemic cardiomyopathy and a major cause of heart failure, but disease-specific molecular biomarkers remain limited. This study aimed to identify and prioritize tissue-level, disease-responsive candidate biomarkers for DCM using an integrative multi-omics bioinformatics framework.
Methods
Bulk myocardial transcriptomic data from GSE57338 were used as the discovery cohort, and GSE26887, GSE42955, and GSE79962 served as external microarray validation cohorts. GSE116250 was used for independent RNA-seq validation. Differentially expressed genes were intersected with WGCNA hub genes to define candidate genes. Four machine-learning algorithms, including LASSO, random forest, SVM-RFE, and XGBoost, were applied to identify core diagnostic candidates. Tissue-level model performance was evaluated by ROC analysis, calibration assessment, nomogram visualization, and decision curve analysis. Orthogonal validation was performed using GTEx, HPA, and snRNA-seq data. Immune infiltration, bidirectional Mendelian randomization, and CellOracle-based GRN analysis with a co-expression-based functional importance score were used as hypothesis-generating analyses. The workflow explicitly separated diagnostic performance, localization evidence, and exploratory mechanistic context in myocardial tissue.
Results
Integration of 309 DEGs and 2,093 WGCNA hub genes yielded 270 candidates. Seven candidates—HMGN2, AQP3, SERPINA3, FREM1, HMOX2, CSDC2, and TUBA3E—were selected by at least three algorithms. In the discovery cohort, the RF model achieved an AUC of 0.985 and the logistic model achieved a C-statistic of 0.993; however, these estimates were interpreted as potentially optimistic upper bounds because feature selection was not nested within cross-validation. External validation showed uneven robustness: SERPINA3, HMOX2, FREM1, and HMGN2 were consistently supported across microarray and RNA-seq cohorts, whereas AQP3, CSDC2, and TUBA3E were exploratory. GTEx, HPA, and snRNA-seq supported cardiac expression and cell-type localization, including cardiomyocyte enrichment of CSDC2/HMOX2 and fibroblast enrichment of FREM1. MR and GRN analyses suggested disease-responsive rather than disease-driving biology, including possible heart failure-associated AQP3 downregulation and a putative PPARGC1A–CSDC2/HMOX2 regulatory context.
Conclusion
This study identifies seven prioritized, predominantly disease-responsive tissue-level molecular candidates for DCM. These findings provide candidates and testable hypotheses for future translational research, rather than disease-driving therapeutic targets or a directly applicable clinical test.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- College of Clinical Traditional Chinese Medicine, Gansu University of Chinese Medicine, Lanzhou, China.
- Department of Oncology, Affiliated Hospital of Gansu University of Traditional Chinese Medicine, Lanzhou, China.
- Gansu Institute of Cardiovascular Diseases, Lanzhou, China.
- College of Integrated Traditional Chinese and Western Medicine, Gansu University of Chinese Medicine, Lanzhou, China.
- Gansu Provincial Hospital of Traditional Chinese Medicine, Lanzhou, China.
Förderung
- National Natural Science Foundation of China
- Science and Technology Program of Gansu Province
Zitieren
APA
Li, J., Song, Z., Wang, G., Chen, Y., Cheng, J., & Zhang, Z. (2026). Identification and multi-layered validation of seven diagnostic biomarkers for dilated cardiomyopathy via integrative machine learning, single-cell transcriptomics, and Mendelian randomization. Frontiers in Cell and Developmental Biology, 14. https://doi.org/10.3389/fcell.2026.1851275
Vancouver
Li J, Song Z, Wang G, Chen Y, Cheng J, Zhang Z. Identification and multi-layered validation of seven diagnostic biomarkers for dilated cardiomyopathy via integrative machine learning, single-cell transcriptomics, and Mendelian randomization. Frontiers in Cell and Developmental Biology. 2026;14. doi:10.3389/fcell.2026.1851275
BibTeX
@article{Li2026,
author = {Li, Jingwei and Song, Zhongyang and Wang, Guanwei and Chen, Yuchan and Cheng, Jiamiao and Zhang, Zhiming},
title = {Identification and multi-layered validation of seven diagnostic biomarkers for dilated cardiomyopathy via integrative machine learning, single-cell transcriptomics, and Mendelian randomization},
journal = {Frontiers in Cell and Developmental Biology},
year = {2026},
volume = {14},
doi = {10.3389/fcell.2026.1851275}
}
EUVIMED